Equity

3 Months Ended

Sep. 30, 2012

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

NOTE 5 – CAPITAL STOCK

Common Stock

The Company has authorized 525,000,000 shares of its common stock, $0.001 par value. The Company had issued and outstanding 82,329,481 shares of its common stock at September 30, 2012 and December 31, 2011.

During the nine month period ended September 30, 2012, the Company did not issue any shares of its common stock for services.

On May 11, 2011, the Company filed a post-effective amendment to its registration statement on Form S-8 with the Securities and Exchange Commission to register an additional 20,000,000 shares of its common stock for issuance under its 2009 Stock Incentive Plan for Employees and Consultants. On September 1, 2011 the Company filed an additional post-effective amendment to further increase the total number of registered shares by an additional 40,000,000 shares, bringing the total shares registered under this Form S-8 to 106,000,000 shares.

Common Stock Warrants

The Company did not issue any common stock purchase warrants during the nine month period ended September 30, 2012. Warrants outstanding are as follows:

	Warrants Outstanding		Weighted Average Exercise Price	Weighted Average Remaining Life

Balance, December 31, 2010	919,230	$	0.06	3.62 years
Warrants issued	-		-
Warrants exercised	-		-
Warrants expired	-		-
Balance, December 31, 2011	919,230		0.06	2.62 years
Warrants issued	-		-
Warrants exercised	-		-
Warrants expired	-		-
Balance, September 30, 2012	919,230	$	0.06	1.87 years

Common Stock Options

The Company did not grant any stock options for shares of its common stock during the nine months ended September 30, 2012.

The Company’s stock option activity for the nine month period ended September 30, 2012 is as follows:

	Options Outstanding		Weighted Average Exercise Price	Weighted Average Remaining Life

Balance, December 31, 2010	34,445,000	$	0.109	3.95 years
Options granted	19,500,000		0.0113
Options exercised	-		-
Options cancelled and expired	-		-
Balance, December 31, 2011	53,945,000		0.069	3.63 years
Options granted	-		-
Options exercised	-		-
Options cancelled and expired	(775,000)		1.50
Balance, September 30, 2012	53,170,000	$	0.049	2.93 years

CELLCYTE GENETICS CORP 10-Q